MX4596E - Procedimiento para preparar un derivado de fenilpiperazina - Google Patents

Procedimiento para preparar un derivado de fenilpiperazina

Info

Publication number
MX4596E
MX4596E MX775629U MX562977U MX4596E MX 4596 E MX4596 E MX 4596E MX 775629 U MX775629 U MX 775629U MX 562977 U MX562977 U MX 562977U MX 4596 E MX4596 E MX 4596E
Authority
MX
Mexico
Prior art keywords
prepare
procedure
phenylpiperazine derivative
phenylpiperazine
derivative
Prior art date
Application number
MX775629U
Other languages
English (en)
Inventor
John Pomfret Verge
William Boffey Mieson
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of MX4596E publication Critical patent/MX4596E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX775629U 1976-04-23 1977-04-13 Procedimiento para preparar un derivado de fenilpiperazina MX4596E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
MX4596E true MX4596E (es) 1982-06-25

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
MX775629U MX4596E (es) 1976-04-23 1977-04-13 Procedimiento para preparar un derivado de fenilpiperazina

Country Status (34)

Country Link
JP (1) JPS52151183A (es)
AR (2) AR222003A1 (es)
AT (1) AT355579B (es)
AU (1) AU514822B2 (es)
BE (1) BE853899A (es)
BG (2) BG27746A3 (es)
CA (1) CA1087617A (es)
CH (2) CH633009A5 (es)
CS (1) CS196360B2 (es)
DD (1) DD129790A5 (es)
DE (1) DE2717415A1 (es)
DK (1) DK176177A (es)
ES (2) ES457988A1 (es)
FI (1) FI63937C (es)
FR (1) FR2348925A1 (es)
GB (1) GB1575904A (es)
GR (1) GR64084B (es)
HU (1) HU176820B (es)
IE (1) IE44730B1 (es)
IL (1) IL51787A (es)
LU (1) LU77170A1 (es)
MX (1) MX4596E (es)
NL (1) NL7704456A (es)
NO (1) NO146710C (es)
NZ (1) NZ183715A (es)
OA (1) OA05643A (es)
PH (1) PH14124A (es)
PL (1) PL117466B1 (es)
PT (1) PT66452B (es)
RO (1) RO72831A (es)
SE (1) SE7704536L (es)
SU (2) SU664564A3 (es)
YU (1) YU104477A (es)
ZA (1) ZA771849B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
US5834499A (en) * 1994-03-11 1998-11-10 Yamanouchi Pharmaceutical Co., Ltd. 5-HT3 receptor agonist, novel thiazole derivative and intermediate thereof
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
JP2009528363A (ja) 2006-02-28 2009-08-06 ヘリコン セラピューティクス,インコーポレイテッド Pde4インヒビターとしての治療用ピペラジン

Also Published As

Publication number Publication date
AU514822B2 (en) 1981-02-26
CA1087617A (en) 1980-10-14
AT355579B (de) 1980-03-10
GR64084B (en) 1980-01-21
DE2717415A1 (de) 1977-11-10
PL197550A1 (pl) 1979-05-21
DD129790A5 (de) 1978-02-08
ZA771849B (en) 1978-11-29
FI771287A (es) 1977-10-24
FI63937B (fi) 1983-05-31
LU77170A1 (es) 1979-01-18
NO771398L (no) 1977-10-25
PT66452B (en) 1979-03-09
IE44730L (en) 1977-10-23
PT66452A (en) 1977-05-01
SU664564A3 (ru) 1979-05-25
FR2348925A1 (fr) 1977-11-18
AR222003A1 (es) 1981-04-15
RO72831A (ro) 1983-08-03
AU2438677A (en) 1978-10-26
BG27746A3 (en) 1979-12-12
ATA285177A (de) 1979-08-15
CH625802A5 (en) 1981-10-15
RO72831B (ro) 1983-07-30
NO146710C (no) 1982-11-24
IL51787A0 (en) 1977-05-31
HU176820B (en) 1981-05-28
CH633009A5 (en) 1982-11-15
ES457988A1 (es) 1978-07-16
BE853899A (fr) 1977-10-24
OA05643A (fr) 1981-04-30
CS196360B2 (en) 1980-03-31
JPS52151183A (en) 1977-12-15
NZ183715A (en) 1980-04-28
BG28055A3 (en) 1980-02-25
DK176177A (da) 1977-10-24
GB1575904A (en) 1980-10-01
NL7704456A (nl) 1977-10-25
PL117466B1 (en) 1981-08-31
ES467948A1 (es) 1978-11-01
SU727146A3 (ru) 1980-04-05
IE44730B1 (en) 1982-03-10
FR2348925B1 (es) 1980-04-11
AR222635A1 (es) 1981-06-15
IL51787A (en) 1980-02-29
YU104477A (en) 1983-01-21
SE7704536L (sv) 1977-10-24
FI63937C (fi) 1983-09-12
PH14124A (en) 1981-02-26
NO146710B (no) 1982-08-16

Similar Documents

Publication Publication Date Title
ES483077A0 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
ES488386A0 (es) Un procedimiento para preparar nuevos derivados heterocicli-cos
SE7806466L (sv) Fenylpiperazinderivat
ES487847A0 (es) Un procedimiento para preparar nuevas fenetanolaminas
AR224494A1 (es) Un procedimiento para preparar cefalexina de accion prolongada
MX4597E (es) Procedimiento para preparar gamma-pironas
ES251105Y (es) Un lizo para tejer
MX6813E (es) Procedimiento para preparar un par emantiomerico piretroide
MX4971E (es) Proceso para preparar un derivado de cortisol
BR7803381A (pt) Disposicao embolo-cilindro para um compressor
MX4596E (es) Procedimiento para preparar un derivado de fenilpiperazina
AR222453A1 (es) Procedimiento para preparar 3-amino-4-carboxi-tiofenos
AR217652A1 (es) Procedimiento para preparar un derivado de 8a-hidroxi o clorooleandomicina
MX149436A (es) Mejoras a un metodo para expandir tabaco
ES486328A0 (es) Un procedimiento para preparar benzoxazepinas
MX5351E (es) Procedimiento para preparar 4-alquiltio-2-trifluorometilalcansulfonanilidas
AR211398Q (es) Un procedimiento para preparar derivados de ( -pirrolin -2- on -1- il)-acilamida
AR225397A1 (es) Un procedimiento para preparar 1-sulfonil sustituido-2-amino-5(6)-sustituido-bencimidazol
BR7801903A (pt) Maquina para fechar rebordos
ES489590A0 (es) Un procedimiento para preparar arilalquil- y ariloxi-alquil-fosfonatos
AR211940A1 (es) Procedimiento para preparar nocardicina a
MX3964E (es) Procedimiento para preparar oxo-benzopiranos
ES481212A0 (es) Un procedimiento para preparar benzoxepinas
AR213309A1 (es) Procedimiento para preparar 2-amino-isotioureidobencenos substituidos
AR227620A1 (es) Procedimiento para preparar 4-desacetoxi-4-alfa-hidroxiindoldihidroindoles